Welcome : Guest

Cytokinetics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cytokinetics, Inc., which is principally a Clinical Stage Biopharmaceutical Company. Illustrated with 12 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-10293
Price: $600
Company Type: Public
Pages: 15
Date: October 2015
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......3
Table 1: Biopharmaceuticals Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......3
Biologics......4
Table 2: Biological Drugs Market by Product Segment Worldwide (2015)-Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......4
Table 3: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......5
Table 4: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......6
Table 5: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......7
Table 6: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......8
Biosimilars......9
Table 7: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......9
Injectables......10
Table 8: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......10
Table 9: Injectables Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......11
Biopharmaceuticals......12
Table 10: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......12
Biosimilars......13
Table 11: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015)-Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......13
Table 12: Cytokinetics, Incorporated’s Revenues by Category Worldwide (2011-2013) in US$ Thousands for Research and Development Revenues from Related Parties, Research and Development, Grant and Other Revenues, License Revenues from Related Parties and License Revenues......14